Figure 1.
This chart describes the active surveillance (AS) cohort. MaRCC Registry indicates the Metastatic Renal Cell Carcinoma Registry; PTSAS, Physician Treatment Selection Assessment Survey; ST, systemic therapy.
This chart describes the active surveillance (AS) cohort. MaRCC Registry indicates the Metastatic Renal Cell Carcinoma Registry; PTSAS, Physician Treatment Selection Assessment Survey; ST, systemic therapy.